Finally, inhibition of MEK1/2 was shown to enhance mitochondrial biogenesis and FAO in stem cell-like memory CD8+ T cells, improving their persistence and supporting antitumor activity in tumor-bearing mice (93). Here, CD8A is linked to neoplasm.